A resurfaced 1990s story collides with fresh allegations against Diddy as hip-hop’s longest-running feud erupts into another public showdown. The […] The post Ja Rule vows lawsuit after 50 Cent ...

A United States federal judge has ruled that former President Donald Trump’s attempt to require documentary proof of citizenship for federal voter registration cannot be enforced, marking a ...

A federal judge in Washington, D.C., on Friday sided with civil rights groups that sued the Trump administration over an executive order requiring proof of citizenship to register to vote. U.S.

President Donald Trump’s request to add a documentary proof of citizenship requirement to the federal voter registration form cannot be enforced, a federal judge ruled Friday. US District Judge ...

NEW YORK >> A federal judge today permanently blocked part of an executive order from President Donald Trump, ruling that the president cannot require voters to show passports or similar documents as ...

India Quotient was the first investor in ShareChat, Sugar Cosmetics, Lendingkart, Kuku FM, Vyapar, and several other startups. India Quotient, an early-stage investor, has raised $129 million in its ...

India Quotient, a Bengaluru-based early-stage venture capital firm, has made the final close of its fifth fund at $129 million (around Rs 1,132 crore), marking its largest fundraise to date. The new ...

With the fund, India Quotient aims to back pre-seed, seed stage Indian startups along with investing in idea stage startups Vice president Sahil Makkar and ex-Upside AI cofounder Kanika Agarrwal have ...

Fred Lucas is chief news correspondent and manager of the Investigative Reporting Project for The Daily Signal. He is the author of “The Myth of Voter Suppression: The Left’s Assault on Clean ...

NOTTINGHAM, England, Oct. 14, 2025 /PRNewswire/ -- Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization ...

The partnership will combine Quotient Sciences' expertise in early clinical development with Biorasi's global patient recruitment capabilities to provide biotech and pharma Sponsors with a simplified, ...